山东大学耳鼻喉眼学报 ›› 2022, Vol. 36 ›› Issue (3): 84-91.doi: 10.6040/j.issn.1673-3770.0.2021.562

• 研究进展 • 上一篇    下一篇

表观遗传学在慢性鼻窦炎伴鼻息肉发病机制中的作用

李佳倪1,朱冬冬1,2,孟粹达1,2   

  1. 1.吉林大学中日联谊医院 耳鼻咽喉头颈外科, 吉林 长春 130033;
    2.吉林省上气道过敏性疾病精准诊疗实验室, 吉林 长春 130033
  • 发布日期:2022-06-15
  • 通讯作者: 孟粹达. E-mail:mengcd@jlu.edu.cn
  • 基金资助:
    国家自然科学基金项目(81870701,82071016);吉林省自然科学基金项目(20200201411JC,20200201600JC,20200201200JC);吉林省重点实验室建设项目(20190901003JC);吉林省卫生科研人才专项项目(2019scz004,2020scz24);吴阶平医学基金会临床科研专项(320675018380)

The role of epigenetics in the pathogenesis of chronic rhinosinusitis with nasal polyps

LI Jiani1, ZHU Dongdong1,2Overview,MENG Cuida1,2   

  1. 1. Department of Otorhinolaryngology & Head and Neck Surgery, China-Japan Union Hospital of Jilin University, Changchun 130033, Jilin, China;
    2. Jilin provincial Key Laboratory of Precise Diagnosis and Treatment of Upper Airway Allergic, Changchun 130033, Jilin, China
  • Published:2022-06-15

摘要: 慢性鼻窦炎伴鼻息肉其确切的发病机制尚未完全明确。表观遗传学(Epigenetics)主要指基于非基因序列改变所致基因表达水平的变化,包括DNA甲基化、组蛋白修饰和非编码RNA调控等。就相关基因的表观遗传学修饰及其引起的相应细胞因子和蛋白质等的表达改变在CRS发病机制中的作用作一综述,从全新的角度认识CRS,为明确其发病过程、探究治疗方法提供新的方向。

关键词: 慢性鼻窦炎, 鼻息肉, 表观遗传学, 甲基化, 发病机制

Abstract: The pathogenesis of chronic rhinosinusitis(CRS)with nasal polyps has not been fully elucidated. Epigenetics mainly refers to changes in gene expression levels based on non-gene sequence changes, such as DNA methylation, histone modification, and microRNA regulation. In this review, the role of epigenetic modification of CRS-related genes and changes in the expression levels of corresponding cytokines and other related proteins in the pathogenesis of CRS are discussed. The aim of this review is to provide new directions for research on the pathogenesis of CRS and the development of therapeutic methods.

Key words: Chronic Rhinosinusitis, Nasal Polyps, Epigenetics, Methylation, Pathogenesis

中图分类号: 

  • R765.4
[1] 李华斌, 赖玉婷, 姜文秀. 慢性鼻窦炎的内表型研究进展及精准治疗[J]. 山东大学耳鼻喉眼学报, 2019, 33(3): 9-13. doi:10.6040/j.issn.1673-3770.1.2018.043. LI Huabin, LAI Yuting, JIANG Wenxiu. Endotypes and precision medicine in chronic sinusitis treatment[J]. Journal of Otolaryngology and Ophthalmology of Shandong University, 2019, 33(3): 9-13. doi:10.6040/j.issn.1673-3770.1.2018.043.
[2] Dykewicz MS, Hamilos DL. Rhinitis and sinusitis[J]. J Allergy Clin Immunol, 2010, 125(2): 103-115. doi: 10.1016/j.jaci.2009.12.989.
[3] Chaaban MR, Walsh EM, Woodworth BA. Epidemiology and differential diagnosis of nasal polyps[J]. Am J Rhinol Allergy, 2013, 27(6): 473-478. doi:10.2500/ajra.2013.27.3981.
[4] North ML, Ellis AK. The role of epigenetics in the developmental origins of allergic disease[J]. Ann Allergy Asthma Immunol, 2011, 106(5): 355-361; quiz362. doi:10.1016/j.anai.2011.02.008.
[5] Ng HH, Adrian B. DNA methylation and chromatin modification[J]. Curr Opin Genet Dev, 1999, 9(2): 158-163. doi:10.1016/S0959-437X(99)80024-0.
[6] Zheng YB, Zhao Y, Yue LY, et al. Pilot study of DNA methylation in the pathogenesis of chronic rhinosinusitis with nasal polyps[J]. Rhinology, 2015, 53(4): 345-352. doi:10.4193/Rhino14.086.
[7] Hew KM, Walker AI, Kohli A, et al. Childhood exposure to ambient polycyclic aromatic hydrocarbons is linked to epigenetic modifications and impaired systemic immunity in T cells[J]. Clin Exp Allergy, 2015, 45(1): 238-248. doi:10.1111/cea.12377.
[8] White GP, Hollams EM, Yerkovich ST, et al. CpG methylation patterns in the IFN-γ promoter in naive T cells: variations during Th1 and Th2 differentiation and between atopics and non-atopics[J]. Pediatr Allergy Immunol, 2006, 17(8): 557-564. doi:10.1111/j.1399-3038.2006.00465.x.
[9] Jundi K, Greene C. Transcription of interleukin-8: how altered regulation can affect cystic fibrosis lung disease[J]. Biomolecules, 2015, 5(3): 1386-1398. doi:10.3390/biom5031386.
[10] van Drunen CM, Reinartz S, Wigman J, et al. Inflammation in chronic rhinosinusitis and nasal polyposis[J]. Immunol Allergy Clin North Am, 2009, 29(4): 621-629. doi:10.1016/j.iac.2009.07.003.
[11] Li JY, Jiao J, Wang M, et al. Hypomethylation of the IL8 promoter in nasal epithelial cells of patients with chronic rhinosinusitis with nasal polyps[J]. J Allergy Clin Immunol, 2019, 144(4): 993-1003.e12. doi:10.1016/j.jaci.2019.06.042.
[12] Soumelis V, Reche PA, Kanzler H, et al. Human epithelial cells trigger dendritic cell mediated allergic inflammation by producing TSLP[J]. Nat Immunol, 2002, 3(7): 673-680. doi:10.1038/ni805.
[13] Nagarkar DR, Poposki JA, Tan BK, et al. Thymic stromal lymphopoietin activity is increased in nasal polyps of patients with chronic rhinosinusitis[J]. J Allergy Clin Immunol, 2013, 132(3): 593-600.e12. doi:10.1016/j.jaci.2013.04.005.
[14] Kimura S, Pawankar R, Mori S, et al. Increased expression and role of thymic stromal lymphopoietin in nasal polyposis[J]. Allergy Asthma Immunol Res, 2011, 3(3): 186-193. doi:10.4168/aair.2011.3.3.186.
[15] Li JY, Jiao J, Gao YB, et al. Association between methylation in nasal epithelial TSLP gene and chronic rhinosinusitis with nasal polyps[J]. Allergy Asthma Clin Immunol Off J Can Soc Allergy Clin Immunol, 2019, 15(1): 71. doi:10.1186/s13223-019-0389-3.
[16] Heljasvaara R, Nyberg P, Luostarinen J, et al. Generation of biologically active endostatin fragments from human collagen XVIII by distinct matrix metalloproteases[J]. Exp Cell Res, 2005, 307(2): 292-304. doi:10.1016/j.yexcr.2005.03.021.
[17] Ergün S, Kilic N, Wurmbach JH, et al. Endostatin inhibits angiogenesis by stabilization of newly formed endothelial tubes[J]. Angiogenesis, 2001, 4(3): 193-206. doi:10.1023/a: 1014027218980.
[18] Zhang Y, Qu ZH, Cui M, et al. Combined endostatin and TRAIL gene transfer suppresses human hepatocellular carcinoma growth and angiogenesis in nude mice[J]. Cancer Biol Ther, 2009, 8(5): 466-473. doi:10.4161/cbt.8.5.7687.
[19] Suzaki Y, Hamada K, Sho M, et al. A potent antiangiogenic factor, endostatin prevents the development of asthma in a murine model[J]. J Allergy Clin Immunol, 2005, 116(6): 1220-1227. doi:10.1016/j.jaci.2005.08.052.
[20] Kidoguchi M, Noguchi E, Nakamura T, et al. DNA methylation of proximal PLAT promoter in chronic rhinosinusitis with nasal polyps[J]. Am J Rhinol Allergy, 2018, 32(5): 374-379. doi:10.1177/1945892418782236.
[21] Takabayashi T, Kato A, Peters AT, et al. Excessive fibrin deposition in nasal polyps caused by fibrinolytic impairment through reduction of tissue plasminogen activator expression[J]. Am J Respir Crit Care Med, 2013, 187(1): 49-57. doi:10.1164/rccm.201207-1292OC.
[22] Kim DY, Cho SH, Takabayashi T, et al. Chronic rhinosinusitis and the coagulation system[J]. Allergy Asthma Immunol Res, 2015, 7(5): 421-430. doi:10.4168/aair.2015.7.5.421.
[23] Kim JY, Kim DK, Yu MS, et al. Role of epigenetics in the pathogenesis of chronic rhinosinusitis with nasal polyps[J]. Mol Med Rep, 2018, 17(1): 1219-1227. doi:10.3892/mmr.2017.8001.
[24] Velimir GM, Hrvoje C, Livije K, et al. Surgical treatment for nasal polyposis: predictors of outcome[J]. Eur Arch Oto Rhino Laryngol Off J Eur Fed Oto Rhino Laryngol Soc EUFOS Affil Ger Soc Oto Rhino Laryngol Head Neck Surg, 2015, 272(12): 3735-3743. doi:10.1007/s00405-015-3519-7.
[25] Sreeparvathi A, Kalyanikuttyamma LK, Kumar M, et al. Significance of blood eosinophil count in patients with chronic rhinosinusitis with nasal polyposis[J]. J Clin Diagn Res, 2017, 11(2): MC08-MC11. doi:10.7860/JCDR/2017/25320.9445.
[26] Ueno S, Weidinger G, Osugi T, et al. Biphasic role for Wnt/beta-catenin signaling in cardiac specification in zebrafish and embryonic stem cells[J]. Proc Natl Acad Sci USA, 2007, 104(23): 9685-9690. doi:10.1073/pnas.0702859104.
[27] Malbon CC. Frizzleds: new members of the superfamily of G-protein-coupled receptors[J]. Front Biosci, 2004, 9: 1048-1058. doi:10.2741/1308.
[28] Lin LZ, Cui L, Zhou WL, et al. Β-Catenin directly regulates Islet1 expression in cardiovascular progenitors and is required for multiple aspects of cardiogenesis[J]. PNAS, 2007, 104(22): 9313-9318. doi:10.1073/pnas.0700923104.
[29] Kim JY, Cha MJ, Park YS, et al. Upregulation of FZD5 in eosinophilic chronic rhinosinusitis with nasal polyps by epigenetic modification[J]. Mol Cells, 2019, 42(4): 345-355. doi:10.14348/molcells.2019.2418.
[30] Benard A, Goossens-Beumer IJ, van Hoesel AQ, et al. Histone trimethylation at H3K4, H3K9 and H4K20 correlates with patient survival and tumor recurrence in early-stage colon cancer[J]. BMC Cancer, 2014, 14: 531. doi:10.1186/1471-2407-14-531.
[31] Snowden AW, Gregory PD, Case CC, et al. Gene-specific targeting of H3K9 methylation is sufficient for initiating repression in vivo[J]. Curr Biol, 2002, 12(24): 2159-2166. doi:10.1016/s0960-9822(02)01391-x.
[32] Bartke T, Vermeulen M, Xhemalce B, et al. Nucleosome-interacting proteins regulated by DNA and histone methylation[J]. Cell, 2010, 143(3): 470-484. doi:10.1016/j.cell.2010.10.012.
[33] Fuks F. DNA methylation and histone modifications: teaming up to silence genes[J]. Curr Opin Genet Dev, 2005, 15(5): 490-495. doi:10.1016/j.gde.2005.08.002.
[34] Andrew J, Tony B, Kouzarides. Regulation of chromatin by histone modifications[J]. Cell Research, 2011, 21(3): 381-395.
[35] Lal G, Bromberg JS. Epigenetic mechanisms of regulation of Foxp3 expression[J]. Blood, 2009, 114(18): 3727-3735. doi:10.1182/blood-2009-05-219584.
[36] Thomas LR, Miyashita H, Cobb RM, et al. Functional analysis of histone methyltransferase g9a in B and T lymphocytes[J]. J Immunol, 2008, 181(1): 485-493. doi:10.4049/jimmunol.181.1.485.
[37] Han SY, Lu J, Zhang Y, et al. Recruitment of histone deacetylase 4 by transcription factors represses interleukin-5 transcription[J]. Biochem J, 2006, 400(3): 439-448. doi:10.1042/BJ20061085.
[38] Lee JH, Chung SW, Park IH, et al. Expression of extracellular matrix metalloproteinase inducer in nasal polyps[J]. Am J Rhinol Allergy, 2010, 24(6): 127-131. doi:10.2500/ajra.2010.24.3503.
[39] Cho JS, Moon YM, Park IH, et al. Epigenetic regulation of myofibroblast differentiation and extracellular matrix production in nasal polyp-derived fibroblasts[J]. Clin Exp Allergy, 2012, 42(6): 872-882. doi:10.1111/j.1365-2222.2011.03931.x.
[40] Cho JS, Moon YM, Park IH, et al. Effects of histone deacetylase inhibitor on extracellular matrix production in human nasal polyp organ cultures[J]. Am J Rhinol Allergy, 2013, 27(1): 18-23. doi:10.2500/ajra.2013.27.3827.
[41] Yang WW, Ernst P. SET/MLL family proteins in hematopoiesis and leukemia[J]. Int J Hematol, 2017, 105(1): 7-16. doi:10.1007/s12185-016-2118-8.
[42] Theocharisa S, Margeli A, Kouraklis G. Peroxisome proliferator activated receptor-gamma ligands as potent antineoplastic agents[J]. Curr Med Chem Anticancer Agents, 2003, 3(3): 239-251. doi:10.2174/1568011033482431.
[43] Wei JJ, Wu XY, Peng Y, et al. Regulation of HMGA1 expression by microRNA-296 affects prostate cancer growth and invasion[J]. Clin Cancer Res, 2011, 17(6): 1297-1305. doi:10.1158/1078-0432.CCR-10-0993.
[44] Bartel DP. Metazoan microRNAs[J]. Cell, 2018, 173(1): 20-51. doi:10.1016/j.cell.2018.03.006.
[45] Turner ML, Schnorfeil FM, Brocker T. microRNAs regulate dendritic cell differentiation and function[J]. J Immunol, 2011, 187(8): 3911-3917. doi:10.4049/jimmunol.1101137.
[46] Luo X, Han MM, Liu JQ, et al. Epithelial cell-derived micro RNA-146a generates interleukin-10-producing monocytes to inhibit nasal allergy[J]. Sci Rep, 2015, 5: 15937. doi:10.1038/srep15937.
[47] Elbehidy RM, Youssef DM, El-Shal AS, et al. microRNA-21 as a novel biomarker in diagnosis and response to therapy in asthmatic children[J]. Mol Immunol, 2016, 71: 107-114. doi:10.1016/j.molimm.2015.12.015.
[48] Zhang XH, Zhang YN, Li HB, et al. Overexpression of miR-125b, a novel regulator of innate immunity, in eosinophilic chronic rhinosinusitis with nasal polyps[J]. Am J Respir Crit Care Med, 2012, 185(2): 140-151. doi:10.1164/rccm.201103-0456OC.
[49] Xuan LJ, Luan G, Wang Y, et al. microRNAs regulating mucin type O-glycan biosynthesis and transforming growth factor β signaling pathways in nasal mucosa of patients with chronic rhinosinusitis with nasal polyps in Northern China[J]. Int Forum Allergy Rhinol, 2019, 9(1): 106-113. doi:10.1002/alr.22230.
[50] Luo XQ, Shao JB, Xie RD, et al. Micro RNA-19a interferes with IL-10 expression in peripheral dendritic cells of patients with nasal polyposis[J]. Oncotarget, 2017, 8(30): 48915-48921. doi:10.18632/oncotarget.16555.
[51] Qing X, Zhang YQ, Peng Y, et al. miR-142-3p regulates inflammatory response by contributing to increased TNF-α in chronic rhinosinusitis with nasal polyposis[J]. Ear Nose Throat J, 2021, 100(1): NP50-NP56. doi:10.1177/0145561319847972.
[52] Mitoma H, Horiuchi T, Tsukamoto H, et al. Molecular mechanisms of action of anti-TNF-α agents - Comparison among therapeutic TNF-α antagonists[J]. Cytokine, 2018, 101: 56-63. doi:10.1016/j.cyto.2016.08.014.
[53] Thorley AJ, Ford PA, Giembycz MA, et al. Differential regulation of cytokine release and leukocyte migration by lipopolysaccharide-stimulated primary human lung alveolar type II epithelial cells and macrophages[J]. J Immunol, 2007, 178(1): 463-473. doi:10.4049/jimmunol.178.1.463.
[54] Ma ZX, Shen Y, Zeng Q, et al. miR-150-5p regulates EGR2 to promote the development of chronic rhinosinusitis via the DC-Th axis[J]. Int Immunopharmacol, 2018, 54: 188-197. doi:10.1016/j.intimp.2017.11.011.
[55] Doncel-Pérez E, Mateos-Hernández L, Pareja E, et al. Expression of early growth response gene-2 and regulated cytokines correlates with recovery from guillain-Barré syndrome[J]. J Immunol, 2016, 196(3): 1102-1107. doi:10.4049/jimmunol.1502100.
[56] Kim TD, Jung HR, Seo SH, et al. microRNA-150 modulates intracellular Ca2+ levels in naïve CD8+ T cells by targeting TMEM20[J]. Sci Rep, 2017, 7(1): 2623. doi:10.1038/s41598-017-02697-x.
[57] Yu HL, Ju JB, Liu JD, et al. Aberrant expression of miR-663 and transforming growth factor-β1 in nasal polyposis in children[J]. Exp Ther Med, 2018, 15(5): 4550-4556. doi:10.3892/etm.2018.5927.
[58] Park IH, Um JY, Hong SM, et al. Metformin reduces TGF-β1-induced extracellular matrix production in nasal polyp-derived fibroblasts[J]. Otolaryngol Head Neck Surg, 2014, 150(1): 148-153. doi:10.1177/0194599813513880.
[59] Luo Q, Zhang ZY, Liu D, et al. Human neutrophil elastase induces MUC5AC overexpression in chronic rhinosinusitis through tumour necrosis factor-α converting enzyme[J]. Acta Otolaryngol, 2016, 136(6): 641-648. doi:10.3109/00016489.2016.1144145.
[60] Wang J, Zhu MC, Wang LL, et al. Amphiregulin potentiates airway inflammation and mucus hypersecretion induced by urban particulate matter via the EGFR-PI3Kα-AKT/ERK pathway[J]. Cell Signal, 2019, 53: 122-131. doi:10.1016/j.cellsig.2018.10.002.
[61] Xu R, Li Q, Zhou J, et al. Secretoneurin induces airway mucus hypersecretion by enhancing the binding of EGF to NRP1[J]. Cell Physiol Biochem, 2014, 33(2): 446-456. doi:10.1159/000358625.
[62] Yan DQ, Ye Y, Zhang J, et al. Human neutrophil elastase induces MUC5AC overexpression in chronic rhinosinusitis through miR-146a[J]. Am J Rhinol Allergy, 2020, 34(1): 59-69. doi:10.1177/1945892419871798.
[63] Choksi SP, Lauter G, Swoboda P, et al. Switching on Cilia: transcriptional networks regulating ciliogenesis[J]. Development, 2014, 141(7): 1427-1441. doi:10.1242/dev.074666.
[64] Spassky N, Meunier A. The development and functions of multiciliated epithelia[J]. Nat Rev Mol Cell Biol, 2017, 18(7): 423-436. doi:10.1038/nrm.2017.21.
[65] Callejas-Díaz B, Fernandez G, Fuentes M, et al. Integrated mRNA and microRNA transcriptome profiling during differentiation of human nasal polyp epithelium reveals an altered ciliogenesis[J]. Allergy, 2020, 75(10): 2548-2561. doi:10.1111/all.14307.
[66] Diesch J, Zwick A, Garz AK, et al. A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancers[J]. Clin Epigenetics, 2016, 8: 71. doi:10.1186/s13148-016-0237-y.
[67] Fenaux P, Mufti GJ, Hellström-Lindberg E, et al. Azacitidine prolongs overall survival compared with conventional care regimens in elderly patients with low bone marrow blast count acute myeloid leukemia[J]. J Clin Oncol, 2010, 28(4): 562-569. doi:10.1200/JCO.2009.23.8329.
[68] Yeo NK, Park WJ, Eom DW, et al. Effects of azathioprine and its metabolites on inflammatory cytokines in human nasal polyp organ cultures[J]. Int Forum Allergy Rhinol, 2019, 9(6): 648-655. doi:10.1002/alr.22303.
[69] Yoon S, Eom GH. HDAC and HDAC inhibitor: from cancer to cardiovascular diseases[J]. Chonnam Med J, 2016, 52(1): 1-11. doi:10.4068/cmj.2016.52.1.1.
[1] 冯思聪,于晓岚,娄丹. 基于囊泡组织Ki67、GM-CSF表达评估Messerklinger中鼻甲成形术对慢性鼻-鼻窦炎合并鼻息肉的效果[J]. 山东大学耳鼻喉眼学报, 2026, 40(3): 31-39.
[2] 翟雪纯,边欣,陈敬彩,邓家钰,叶子,杨萍丽. 慢性额窦炎患者焦虑抑郁特点及横断面研究[J]. 山东大学耳鼻喉眼学报, 2026, 40(2): 35-43.
[3] 刘一洁,卢秀珍,吴秋欣. 外泌体在眼病发病机制和诊疗中的研究进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 135-141.
[4] 李阳松,袁发洋,杨艳,张田,喻国冻. 基于Web of Science进行生物制剂治疗慢性鼻窦炎文献计量学分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 54-64.
[5] 杜康丽,郑振宇,徐战将,张宇,陈露,卢梦垚. 鼻中隔偏曲并发慢性鼻窦炎风险预测模型的构建与验证[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 78-86.
[6] 熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[7] 张家齐,袁野,洪陈,顾敏,程雷,陆美萍. 基于孟德尔随机化的肠道菌群与慢性鼻窦炎鼻息肉的因果关系及代谢物中介研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 49-60.
[8] 张广玲,陈兴雪,武天义,孙占伟,王卫卫,李世超,王广科. Tespa1在慢性鼻窦炎伴鼻息肉中的表达及作用研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 35-42.
[9] 曹正勇,李小波. 慢性鼻-鼻窦炎合并哮喘术后短程局部使用糖皮质激素辅助治疗的安全性和有效性[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 43-50.
[10] 潘佳煜,张春林. 急性低频感音神经性听力下降病因及发病机制的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 126-131.
[11] 王文晴,张丹,朱梦迪,王路阳,杨培培,孙思思,张秋敏,周慧. 慢性鼻窦炎伴鼻息肉复发手术时临床及组织病理学特征变化[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 46-53.
[12] 王奥维,时文杰. CRSwNP中医证型与TFH细胞相关因子的相关性研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 54-60.
[13] 张婕,尼玛吉宗,徐小东,周菁,刘建敏,罗依蕤,杜进涛,巴罗. 藏红花素在嗜酸性慢性鼻窦炎伴鼻息肉中调控2型炎症反应的研究[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 61-67.
[14] 石忠刚,蔡晓岚,李学忠,张立强,冯昕. 上颌骨囊肿并内翻性乳头状瘤1例并文献复习[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 123-129.
[15] 张韵秋,任秀敏,徐鸥,董金辉,王建星. 奥马珠单抗靶向治疗慢性鼻窦炎伴鼻息肉的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 136-140.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!